JBS (JBS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved record net revenue of $21 billion in 2Q25, up 8.9% year-over-year, with net income rising 61% to $528 million and EPS at $0.48.
Completed dual listing on NYSE and B3 in June 2025, expanding global visibility and investor base.
Paid $1.2 billion in dividends and announced a $400 million share repurchase program.
Continued strategic investments in U.S. prepared foods, including new and expanded facilities totaling over $800 million.
Maintained global diversification with sales in over 180 countries and a workforce exceeding 280,000.
Financial highlights
Adjusted EBITDA (IFRS) was $1.894 billion, margin 9.8%; adjusted operating income $1.2 billion, margin 5.7%.
Net profit was $528 million; adjusted net income $583 million.
EPS was $0.48; adjusted EPS $0.53.
ROE reached 25.7%; ROIC at 17.0%.
Free cash flow was negative $55 million, impacted by higher inventories, settlements, and increased CAPEX.
Outlook and guidance
Management expects leverage to end the year below 2.5x, with stable interest coverage.
Free cash flow break-even estimated at $5.5 billion for 2025 and $4.5 billion for 2026.
Capital expenditures planned at $2 billion annually for 2025 and 2026.
Confident in gradual improvement in U.S. beef margins from late 2025 into 2028.
U.S. pork margins expected to normalize from Q3 2025 onward.
Latest events from JBS
- Record 2025 revenue and net income, with margin pressures but continued global expansion.JBS
Q4 202526 Mar 2026 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 20241 Feb 2026 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 202413 Jan 2026 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 202420 Dec 2025 - Record profit and sales, strong poultry and pork margins, and dual listing plans despite beef headwinds.JBS
Q1 202518 Nov 2025 - Record sales rose 13% to $22.6B, but margins and profitability declined in Q3.JBS
Q3 202514 Nov 2025 - Global protein leader with strong brands, margin growth, and dual NYSE/B3 listing for future expansion.JBS
CAGNY 2025 Presentation3 Jul 2025 - Global protein leader with robust growth, strong brands, and disciplined financial strategy.JBS
JBS Day 2025 Presentation3 Jul 2025 - Strategic global expansion, margin growth, and disciplined capital allocation drive long-term value.JBS
Investor Presentation26 Jun 2025